Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.
Acute Myocardial Infarction
About this trial
This is an interventional treatment trial for Acute Myocardial Infarction focused on measuring Inflammation, Thrombosis, Hyperglycemia, Myocardial Infarction, Angioplasty
Eligibility Criteria
Inclusion Criteria: Patients to be treated with percutaneous coronary intervention for myocardial infarction. Exclusion Criteria: MI > 6 hrs duration Thrombolytic therapy (within last 2 days) Recent inflammatory/infectious illness (last 2 weeks) Pregnancy Renal insufficiency (Cr > 2.0) Type I Diabetes Mellitus Initial BG >110 but <140 Enrollment in another research study
Sites / Locations
- Emory University Hospital
- Emory Crawford Long Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Angioplasty with Insulin
Angioplasty w/o Insulin
Coming in with acute infarct and received angioplasty with intensive insulin therapy
Coming in with acute infarct and received angioplasty